• HAD_BanNer_01

ପ୍ରିଣ୍ଟାଇଜ୍ ପ୍ରୋଟିନ୍ ପାଇଁ ବ୍ୟବହୃତ ଆମିନୋ ଏସିଡ୍ ର ଅପରିଷ୍କାରତା |

ସଂକ୍ଷିପ୍ତ ବର୍ଣ୍ଣନା:

NO

ଉତ୍ପାଦଗୁଡିକ

କାସ ନା

1

FMOC-D-ALA-D-ALA-OH

NA

2

FMOC-β-ALA-D-ALA-OH

NA

3

FMOC-ARG (PBF) -AG (PBF) -OH |

NA


ଉତ୍ପାଦ ବିବରଣୀ

ଉତ୍ପାଦ ଟ୍ୟାଗ୍ |

ଉତ୍ପାଦ ବିବରଣୀ

NO

ଉତ୍ପାଦଗୁଡିକ

କାସ ନା

ମୁଖ୍ୟ ଗୁଣବତ୍ତା ସୂଚକ |

ଶୁଦ୍ଧତା

ସର୍ବାଧିକ

ଅପରିଷ୍କାରତା

ସମୁଦାୟ ଦ୍ରବଣୀୟ ଅବଶିଷ୍ଟ |

ଆର୍ଦ୍ରତା

1

FMOC-β-ALA-ALA-ALA-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

FMOC-D-ALA-D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

FMOC-β-ALA-D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

FMOC-ARG (PBF) -AG (PBF) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-ALA-ALA-ALA-ALA-

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

FMOC-D- ଯୁଗ (pbf) -d-neg (pbf) -oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-ALA-D-D-D-AGH (PBF) -ୋଜ୍ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

FMOC-HOGARG (PBF) -ହୋମାର୍ଗ୍ (PBF) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-ALA-ALA-HOMARG (PBF) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

FMOC-ASN (TRT) -ASN (TRT) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

FMOC-β-ALA-ALN (TRT) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

FMOC-ASP (Otbu) -asp (ଓଟବୁ) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-ALA-ASP (Otbu) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

FMOC-CYS (TRT) -CYS (TRT) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

FMOC-β-ALA-SYS (TRT) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

FMOC-CYS (ACM) -CYS (ACM) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

FMOC-β-ALA-CYS (ACM) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

FMOC-GLN (TRT) -GLN (TRT) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-ALA-GLN (TRT) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

FMOC-GLU (OTBU) -glu (OTBU) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-β-ALA-GLU (OTBU) -OH.H2O |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

FMOC-β-ALA-GLY-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

FMOC-HE (TRT) -HIS (TRT) -ହୋ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-β-ALA-ALA-HE (TRT) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

FMOC-Ile-Ile-Oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-ALA-Ile-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

FMOC-LEU-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

FMOC-β-ALA-LEU-O OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

FMOC-D-LEU-D-LEU-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

FMOC-β-ALA-D-LEU-O OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

FMOC-LYS (BOC) - (BOC) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-ALAY (BOC) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

FMOC-LYS (ALLOC) - ଆଚ୍ଛା (ALLC) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

FMOC-β-ALAY (ALLOG) -H |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

FMOC-MEN- TEL- OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

FMOC-β-ALA-TEL- OH OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

FMOC-ORN (BOC)-ERON (BOC) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

FMOC-β-ALA-ALA-ORN (BOC) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

FMOC-PHE-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

FMOC-β-ALA-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

FMOC-D-PHE-D-PHE-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

FMOC-β-ALA-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

FMOC-Pro-Pro-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

FMOC-β-ALA-PRO-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

FMOC-ser (tbu) -ser (Tbu) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-Ala-ser (Tbu) -h |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

FMOC-ser (trt) -ser (trt) -oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

FMOC-β-Ala-ser (trt) -hol |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

FMOC-THR (Tbu) -thr (tbu) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

FMOC-β-ALA-THR (TBU) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) --rp (BOC) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

FMOC-β-ALA-TRP (BOC) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -d-trp (Boc) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

Fmoc-β-Ala-d-trp (boc) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

FMOC-Tyr (Tbu) -tyr (tbu) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-Ala-tyr (tbu) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

FMOC-D-TYR (ET) -D-TYR (ET) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

FMOC-β-ALA-D-D-TYR (ET) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

FMOC-Tyr (me) -tyr (me) -oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

FMOC-β-ALA-Ty-Tyr (me) -oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

FMOC-VAL-VAL-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

FMOC-β-ALA-VAL-AHT |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

FMOC-D-KIT-DI CIT-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

FMOC-β-ALA-D-CIT-OH OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

FMOC-β-ALA-DAB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

FMOC- (୨-NAAPHTHIL) -d-ALA) 2-ଓ oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-β-ALA-ALA-3- (2-NAAPHTHIL) -D-ALA-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

FMOC- (3- ୨-ପିଆଡିନିଲ୍) -d-ALA) 2-ଓ oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-β-ALA-ALA-3- (3-ପିଆଡରିଲ୍) -d-ALA-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

FMOC- (4-କ୍ଲୋରୋ-ଡି-ପେ) 2-ଓ oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

FMOC-β-ALOO- CLLORO-D-PHE-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

FMOC- (D-4AH (TBUCBM)) 2-OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-β-ALA-D-D-C -AH (TBUCBM) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

FMOC-APH (L-HOR) -AHH (L-HOR) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-ALA-APH (L-HOR) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

FMOC-LYS (IPR, BOC) - IPR, BOC) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

FMOC-β-ALA-ALS (IPR, BOC) -ୋଜ୍ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

FMOC-β-ALA-AEAA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

FMOC-AIB-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

FMOC-β-ALA-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

FMOC-ARG-OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H- ଯୁଗ (pbf) -ହ |

200115-2-2-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

FMOC-D-ARG-OH

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

HD-ARG (PBF) -OH

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

FMOC-EMORG-OH.HCL |

208174-14-5-

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H- ହୋମରଗ୍ (PBF) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

FMOC-D-WOMARG-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-EMORG (PBF) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

FMOC-ASN-OH

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-Asn (trt) -oh

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

FMOC-ASP-OH

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-Asp (Otbu) -ହ |

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

FMOC-CYS-OH

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-CYS (TRT) -OH

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-CYS (ACM) -OH.HCCL |

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

FMOC-GLN-OH

71989-20-3-3-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-GlN (TRT) -OH

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

FMOC-GLU-OH

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H- ଗ୍ଲୁ (ଓଥୁ) -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

FMOC-ତାଙ୍କର-ଓହ |

116611-4-4-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-ତାଙ୍କର (TRT) -OH

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-ho

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

FMOC-LYS-OH

105047-4-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-LYS (BOC) -ହ |

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-lys (ALLL) -OH |

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

FMOC-OHN-OH.HCL |

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-orn (boc) -ହ |

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

FMOC-Sew-OH

73724-4-4-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-ser (tbu) -ହ |

188222-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

FMOC-THR-OH.H2O |

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-thr (tbu) -oh

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

FMOC-TRP-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H- TRP (BOC) -OH |

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

FMOC-D-TRP-OH

86123-1-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-TRP (BOC) -ହ |

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

FMOC-Tyr-Oh

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-Tyr (Tbu) -ହ |

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

FMOC-D-Tyr-Oh

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-Tyr (et) -oh |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-Tyr (me) -oh.lcl |

67423-44-3-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4AH (CBM) -ହ |

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

HD-4AH (TBUCBM) -OH |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

FMOC-LYS (IPR) -ହ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-LYS (IPR, BOC) -ୋଜ୍ |

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

ବିଷୟରେ

କ୍ଷତିପୂରଣ

ଜେନୋଲିକ୍ସ ବହୁତ ଭଲ ଗୁଣବତ୍ତା ଉତ୍ପାଦ ପ୍ରଦାନ କରିଥାଏ, ଯଦି ପର୍ଯ୍ୟାପ୍ତ ପରିମାଣର ପ୍ରମାଣ ସହିତ ଆବଶ୍ୟକ ସମୟ ସୀମା ମଧ୍ୟରେ ଯେକ Any ଣସି ଉତ୍ପାଦ ଗୁଣକୁ କ୍ଲାଏଣ୍ଟ ଦ୍ୱାରା ବିମୁଖାଯାଉଛି, ତେବେ ଫେରସ୍ତ

ଉତ୍ପାଦନ

ଫାର୍ମାସ୍ୟୁଟିକାଲ୍ ଉତ୍ପାଦଗୁଡିକର କ୍ଷମତା ଟନ୍ ଗ୍ରେଡ୍ ରେ ପହଞ୍ଚିଛି, ରାସାୟନିକ ଉତ୍ପାଦଗୁଡିକର ସାମଗ୍ରୀର 100tons + ଗ୍ରେଡ୍ ରେ ପହଞ୍ଚିଛି, ସାମର୍ଥ୍ୟଗୁଡିକ ବିଶ୍ worldwide ବ୍ୟାପୀ ଗ୍ରାହକମାନଙ୍କୁ ସେବା କରିବା ପାଇଁ ସଜ୍ଜିତ |

ଅନୁସନ୍ଧାନ ଏବଂ ବିକାଶ

ପ୍ରତିବର୍ଷ, ଟାର୍ଗେଟ୍ ସେଟ୍ ସେଟ୍ ହୋଇଥିବାବେଳେ, ଟାର୍ଗେଟ୍ ସେଟ୍ ହୁଏ, ଯେତେବେଳେ ଟାର୍ଗେଟ୍ ସେଟ୍ ହୁଏ, ସେତେବେଳେ ବିଭିନ୍ନ ନୂତନ ଉତ୍ପାଦଗୁଡ଼ିକର ବିକାଶ କରିବାକୁ ଯୋଜନା ପାଖରେ R & d ଦଳ ଦ୍ୱାରା ଯୋଜନା ଅଛି, ଯେତେବେଳେ ଟାର୍ଗେଟ୍ ସେଟ୍ ହୁଏ, ଦଳରେ କେପି ଦାୟିତ୍ and ଏବଂ ପ୍ରୋତ୍ସାହନ ନୀତି ସହିତ ଚାଲିବାକୁ ପଡିବ |


  • ପୂର୍ବ:
  • ପରବର୍ତ୍ତୀ:

  • ଏଠାରେ ଆପଣଙ୍କର ବାର୍ତ୍ତା ଲେଖନ୍ତୁ ଏବଂ ଏହାକୁ ଆମକୁ ପଠାନ୍ତୁ |